Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc for Prevention of Oral Mucositis in Pediatric Acute Lymphoblastic Leukemia
NCT04321850Terminated
- Sponsor
- National Institute of Pediatrics
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in oral mucositis (OM) comparing Group 1 (Placebo) with Group 2 (Zinc) (2 arms). Primary endpoints: Incidence of oral mucositis at 2.5 months, Oral mucositis grade and 1 more. Started Jun 2019; status: terminated.
02
Drugs
zinc
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT04321850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04321850.